Global burden of depressive disorders in the year 2000

By Tevfik Bedirhan Üstün, J. Ayuso-Mateos, S. Chatterji, Colin D Mathers, C. Murray. British Journal of Psychiatry, 2004

1,739 citations recorded by the source corpus.

Subfields: Clinical Psychology, Pharmacology, Social Psychology

View Paper: https://www.semanticscholar.org/paper/00133b61c66684098bf66605121ad38300c9a79e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. Ronald C. Kessler
2. David R. Williams
3. N. Sampson
4. Derek Richards
5. E. Bromet
6. Peter Fonagy
7. R. Nesse
8. I. Hwang

In Pharmacology

1. Derek Richards
2. Jordi Alonso
3. Douglas F. Levinson
4. R. Nesse
5. Thomas Richardson

In Social Psychology

1. N. Sampson
2. David R. Williams
3. G. de Girolamo
4. I. Hwang
5. E. Bromet
6. J. Posada-villa
7. J. Jackson
8. R. Nesse

Citations in the corpus

• Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. (2007, background): “Worldwide, it is the fourth leading cause of disability and the leading cause of nonfatal disease burden, accounting for almost 12% of total years lived with disability.(6) In the United States, the economic burden of depression was estimated to be $83 billion in 2000.”
• Cross-national epidemiology of DSM-IV major depressive episode (2011, background): “Major depression is a serious, recurrent disorder linked to diminished role functioning and quality of life, medical morbidity, and mortality [1,2].”
• Prevalence and clinical course of depression: a review. (2011, methodology): “As well as a high prevalence in women, duration is often longer for females than for males (Ayuso-Mateos et al., 2001; Bebbington et al., 1998; Üstün et al., 2004).”
• The development of a brief psychodynamic protocol for depression: Dynamic Interpersonal Therapy (DIT) (2010, background): “It interferes with social and occupational functioning, it is associated with considerable morbidity and carries a significant risk of mortality through suicide (Ustun, Ayuso-Mateos, Chatterji, Mathers, & Murray, 2004 ).”
• The economic burden of adults with major depressive disorder in the United States (2005 and 2010). (2015, methodology): “Direct costs were estimated according to employment and MDD treatment status: (1) employed and treated—costs estimated from claims data; (2) employed and not treated— MDD costs set equal to 0, and non-MDD costs (the second and third cost categories above) set equal to those incurred by employed and ”
• Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature (2012, background): “The GBD 2000 update predicted an average incidence of 3.2% in males and 4.9% in females (Ayuso-Mateos, 2000 ; Üstün et al. 2004), which was higher than our results of 2.7% in males and 3.4% in females.”